Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/37285
Title: A systematic approach for testing expression of human full-length proteins in cell-free expression systems
Authors: Langlais, Claudia
Guilleaume, B.
Wermke, N.
Scheuermann, T.
Ebert, L.
LaBaer, J.
Korn, B.
First Published: 3-Oct-2007
Publisher: BioMed Central
Citation: BMC Biotechnology20077:64
Abstract: Background The growing field of proteomics and systems biology is resulting in an ever increasing demand for purified recombinant proteins for structural and functional studies. Here, we show a systematic approach to successfully express a full-length protein of interest by using cell-free and cell-based expression systems. Results In a pre-screen, we evaluated the expression of 960 human full-length open reading frames in Escherichia coli (in vivo and in vitro). After analysing the protein expression rate and solubility, we chose a subset of 87 plasmids yielding no protein product in E. coli in vivo. These targets were subjected to a more detailed analysis comparing a prokaryotic cell-free E. coli system with an eukaryotic wheat germ system. In addition, we determined the expression rate, yield and solubility of those proteins. After sequence optimisation for the E. coli in vitro system and generating linear templates for wheat germ expression, the success rate of cell-free protein expression reached 93%. Conclusion We have demonstrated that protein expression in cell-free systems is an appropriate technology for the successful expression of soluble full-length proteins. In our study, wheat germ expression using a two compartment system is the method of choice as it shows high solubility and high protein yield.
DOI Link: 10.1186/1472-6750-7-64
ISSN: 1472-6750
eISSN: 1472-6750
Links: http://bmcbiotechnol.biomedcentral.com/articles/10.1186/1472-6750-7-64
http://hdl.handle.net/2381/37285
Version: Publisher Version
Status: Peer-reviewed
Type: Journal Article
Rights: © Langlais et al.; licensee BioMed Central Ltd. 2007 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Appears in Collections:Published Articles, MRC Toxicology Unit

Files in This Item:
File Description SizeFormat 
art%3A10.1186%2F1472-6750-7-64.pdfPublisher version747.49 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.